Is milk thistle effective in cancer treatment?

	Tweet

Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.

The current issue of Integrative Cancer Therapies (ICT) published by SAGE, contains a summary of current research on and clinical application of silymarin, the mixture of chemicals found in milk thistle. 

The special issue features new research from Morgan Stanley Children’s Hospital of New York-Presbyterian and Columbia University Medical Center finding liver-protective effects for silymarin in children receiving cancer chemotherapy. Guest edited by Drs. Kara Kelly, Janice Post-White, and Elena Ladas, the issue covers the entire scope of milk thistle use in cancer treatment, as well as in fighting other diseases like hepatitis C, diabetes, and HIV, reporting on such subjects as:

* Recent advances in the use of milk thistle

* Clinical trials evaluating the safety and efficacy of milk thistle

* The molecular makeup of silymarin

* Benefits of silymarin use before and during toxic insults to the liver, including damage from alcohol; cancer chemotherapy and other drugs; solvents; and mushroom poisoning

* Direction for future research on milk thistle for cancer patients

“This special issue presents both preclinical and clinical studies demonstrating the potential role of milk thistle as an anticancer agent. No other medications or supplements are currently available that preserve liver function and provide clinical benefits,” write the guest editors in their opening editorial.

“The clinical potential for a liver-protective supplement in cancer care is significant, as I’ve observed in many years of integrative medical practice,” writes Dr. Keith Block, ICT editor. “Several chemotherapy drugs, as well as many of the other drugs cancer patients take, have extremely problematic liver toxicities. With this exclusive edition, the scientific community will have a resource to guide and inspire further research on this very interesting herbal medicine.”

###

The special issue of Integrated Cancer Therapies, guest edited by Kara Kelly, M.D. and Elena Ladas, both at Morgan Stanley Children’s Hospital and Columbia University Medical Center, and Janice Post-White, RN, PhD, FAAN, of the University of Minnesota, is available for a limited time at http://ict.sagepub.com/current.dtl.

About SAGE

SAGE Publications is a leading international publisher of journals, books, and electronic media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology and medicine. A privately owned corporation, SAGE has principal offices in Los Angeles, London, New Delhi, and Singapore. http://www.sagepublications.com

Contact: Judy Erickson

SAGE Publications

RELATED STORIES:
Low testosterone a problem in cancer: study   UV light improving chances of fighting cancer   9/11 firefighters have higher cancer risk: study   End of life care for cancer patients differs in US and Canada   Few young cancer survivors get best follow-up   Pfizer’s Sutent improves survival in cancer study   Lung cancer tied to family risk of other cancers   Researchers present new findings on cancer and gene therapy   Alcohol and cancer: is drinking the new smoking?   Cancer Research Highlights   Doctors Hesitate to Discuss Fertility Preservation With Cancer Patients   How to recognize at an early stage whether a new cancer therapy prolongs life   Tumor metastasis with a twist   New Hybrid virus may aid treatment of cancer   Vitamin D Reduces Cancer Risk   New atlases detail global cancer burden   Low vitamin D tied to cancer risk in men   Getting down to cancer basics   Cancer cell resistance to chemotherapy drugs   Cancer patients, doctors talk little of emotions   Study links infections with some childhood cancers   Cancer drug Gleevec may damage heart: study

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]